OpenAI Hires Co-Founder of Social Platform Rival to X
Gabor Cselle, a serial entrepreneur, was a Twitter employee a decade ago. More recently he helped start Pebble, a safety-centric competitor to Elon Musk’s X. What’s OpenAI up to now?
Read more at Inc.
Topics
-
Middle East latest: Social platform X suspends new account on behalf of Iran's supreme leader
World - ABC News - October 28 -
OpenAI hires first chief economist
Politics - The Hill - October 22 -
OpenAI Hires Aaron Chatterji to Be Its Chief Economist
Tech - The New York Times - October 22 -
How Elon Musk’s X Account Dominates the Platform Ahead of the Election
Business - The New York Times - Yesterday -
Ahead of the Election, Social Media Platforms Have Given Up
Tech - Wired - 4 days ago -
Reddit’s stock soars after social-media platform turns a profit, beats Q3 sales and earnings estimates
Business - MarketWatch - 6 days ago -
Why This Founder Started a Benefits Platform Designed to Make Fertility Care Easier
Business - Inc. - October 21 -
Trump's social media company is now worth more than Musk's X after recent surge in stock price
Tech - ABC News - 6 days ago
More from Inc.
-
When Hurricanes Hit, This Company Helps Keep the Lights On
Business - Inc. - 3 hours ago -
Why Security Companies Are Seeing an Uptick in Protection Requests
Business - Inc. - 4 hours ago -
Election Stresses Could Impact Worker Productivity. Here’s What You Need to Know–and How to Manage It
Business - Inc. - 6 hours ago -
Quincy Jones, Music Titan Who Worked With Artists from Sinatra to Michael Jackson, Dies at 91
Business - Inc. - 7 hours ago -
Trump’s Pro-Business Stance Might Be Outweighed by Chaos, Dealmakers Say
Business - Inc. - 8 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 1 hour ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago